European Journal of Haematology

Papers
(The H4-Index of European Journal of Haematology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Issue Information115
71
The association of age and adverse events of PEG‐asparaginase in a pediatric tertiary care hospital; a retrospective review44
43
Clinical efficacy of simoctocog alfa versus extended half‐life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matching‐adjusted indirect41
Issue Information33
Issue Information32
Comparison of Hetrombopag and Eltrombopag Added to First‐Line Immunosuppressive Therapy in Severe Aplastic Anemia30
Plasma microbial cell‐free DNA following chimeric antigen receptor T cell therapy in pediatric patients with relapsed/refractory leukemia29
Myeloproliferative Neoplasms and Dementia Risk: A Population‐Based Cohort Study28
Augmenter of liver regeneration promotes drug resistance of acute lymphoblastic leukemia through the alteration of mitochondrial functions and the inhibition of the mitochondrial apoptosis pathway27
Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes25
Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity‐induced rash in patients with multiple myeloma24
Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes23
Utilization and outcome disparities in allogeneic hematopoietic stem cell transplant in the United States22
Long‐term effectiveness of eculizumab: Data from the International PNH Registry22
Application of thromboelastography to predict the severity of bleeding after chimeric antigen receptor (CAR)‐T cell therapy in patients with hematological malignancy21
Flow cytometry for comprehensive assessment of platelet functional activity in response to ADP stimulation21
Effects of tertiary palliative care on the pattern of end‐of‐life care in patients with hematologic malignancies in Korea20
0.15278005599976